GST-HG131

DRUG2 trials

Sponsors

Fujian Akeylink Biotechnology Co., Ltd.

Conditions

Chronic Hepatitis B

Phase 2

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

RecruitingNCT06263959

Fujian Akeylink Biotechnology Co., Ltd.Chronic Hepatitis B

Start: 2023-12-26End: 2025-05-01Target: 45Updated: 2025-03-05

Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B

RecruitingNCT07709520

Fujian Akeylink Biotechnology Co., Ltd.Chronic Hepatitis B

Start: 2026-07-10End: 2026-12-01Target: 80Updated: 2026-07-17